Q1 2018 Earnings Estimate for Cooper Companies Inc (COO) Issued By KeyCorp

Cooper Companies Inc (NYSE:COO) – Investment analysts at KeyCorp reduced their Q1 2018 earnings estimates for shares of Cooper Companies in a research report issued to clients and investors on Friday. KeyCorp analyst M. Mishan now expects that the medical device company will post earnings of $2.32 per share for the quarter, down from their previous estimate of $2.63. KeyCorp currently has a “Hold” rating on the stock. KeyCorp also issued estimates for Cooper Companies’ Q2 2018 earnings at $3.06 EPS, Q3 2018 earnings at $3.02 EPS and Q4 2018 earnings at $3.11 EPS.

Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The company had revenue of $561.50 million for the quarter, compared to analyst estimates of $558.86 million. During the same period in the prior year, the firm earned $2.28 earnings per share. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year.

A number of other analysts have also weighed in on COO. Zacks Investment Research lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Monday, August 14th. Jefferies Group set a $250.00 target price on shares of Cooper Companies and gave the stock a “buy” rating in a research note on Thursday, August 17th. Cleveland Research reiterated a “buy” rating on shares of Cooper Companies in a research note on Tuesday, August 22nd. Robert W. Baird reiterated a “buy” rating and issued a $251.00 price target on shares of Cooper Companies in a research note on Thursday, August 24th. Finally, Piper Jaffray Companies increased their price target on shares of Cooper Companies from $265.00 to $280.00 and gave the company an “overweight” rating in a research note on Friday, September 1st. Six research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $259.70.

Cooper Companies (COO) traded up $1.89 during mid-day trading on Monday, hitting $228.45. 774,200 shares of the company were exchanged, compared to its average volume of 427,958. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.41 and a quick ratio of 1.26. Cooper Companies has a 12-month low of $169.39 and a 12-month high of $256.39. The stock has a market capitalization of $11,089.94, a price-to-earnings ratio of 23.31, a price-to-earnings-growth ratio of 1.83 and a beta of 0.54.

In other news, Director Gary S. Petersmeyer sold 3,977 shares of the stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total value of $974,126.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the business. ProVise Management Group LLC lifted its holdings in Cooper Companies by 0.6% in the second quarter. ProVise Management Group LLC now owns 1,177 shares of the medical device company’s stock valued at $282,000 after acquiring an additional 7 shares during the period. YorkBridge Wealth Partners LLC increased its position in shares of Cooper Companies by 2.1% in the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock valued at $126,000 after buying an additional 11 shares in the last quarter. Wedbush Securities Inc. increased its position in shares of Cooper Companies by 1.0% in the second quarter. Wedbush Securities Inc. now owns 1,783 shares of the medical device company’s stock valued at $427,000 after buying an additional 18 shares in the last quarter. Sentry Investment Management LLC increased its position in shares of Cooper Companies by 0.7% in the second quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock valued at $671,000 after buying an additional 19 shares in the last quarter. Finally, Suntrust Banks Inc. increased its position in shares of Cooper Companies by 0.6% in the second quarter. Suntrust Banks Inc. now owns 6,616 shares of the medical device company’s stock valued at $1,583,000 after buying an additional 40 shares in the last quarter. 96.79% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Week Herald and is owned by of Week Herald. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://weekherald.com/2017/12/12/q1-2018-earnings-estimate-for-cooper-companies-inc-coo-issued-by-keycorp.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply